Two-drug combination could improve colorectal cancer therapy (IMAGE)

University of Barcelona

Two-drug combination could improve colorectal cancer therapy

Caption

University of Barcelona's study proposes the combined use of palbociclib and telaglenastat to prevent and counteract the resistance that cancer cells develop to anticancer therapies.  Above, from left to right, Pablo Añón, Pedro Sobral, Ana Ortiz, Malena Manzi, Marta Cascante, Josep J. Centelles, Pedro de Atauri, Francesc Mas, Hengxin Huang, Sergio Madurga and Silvia Marin. Below, from left to right, Miriam Tarrado-Castellarnau, Carlota Shi Mitjana, David López-Blanco, Alejandro Tapia, Sergi Pujol and Núria Aleixandre.

Credit

UNIVERSITY OF BARCELONA

Usage Restrictions

Credit must be given to the creator.

License

CC BY

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.